U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07455422) titled 'A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer' on Feb. 20.
Brief Summary: The goal of the study is:
* The collection of various tissue samples (blood, biopsies and "esophageal brushes") and their analysis.
* To test a risk model based on genetic analyses (DNA-FISH and so-called single cell sequencing) on esophageal tissue samples.
* Evaluating the quality of life of Barrett's Esophagus patients and the degree of fear of getting cancer.
Patients with a Barrett's Eso...